The general-partner team combines biotech, clinical, operating and healthcare transaction experience relevant to Aether's strategy. Detailed CVs and transaction roles are available for investor diligence.
BioViva founder; regenerative-medicine strategy, asset development and global relationships.
Healthcare M&A, operating integration and clinical asset development.
Fund architecture, capital allocation and global biotechnology investing.
Healthcare opportunity sourcing, clinical/translational diligence, evidence & RWE strategy, and portfolio oversight.
Capital-markets strategy, investor relationships and financing coordination.
Important information. Confidential discussion material for accredited investors only; not an offer or solicitation. Team and adviser roles are described for context and are subject to definitive documentation. Nothing here is a performance representation, promise or guarantee.
